vs
Columbia Financial, Inc.（CLBK）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是Columbia Financial, Inc.的1.1倍（$75.5M vs $68.8M），Columbia Financial, Inc.同比增速更快（29.7% vs 27.7%），Columbia Financial, Inc.自由现金流更多（$58.6M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 17.7%）
哥伦比亚金融公司（CLBK）是一家美国多元化金融服务及银行控股企业，提供财富管理、资产管理、保险、年金、遗产规划在内的全方位金融规划产品与服务，满足客户不同阶段的财务规划需求。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
CLBK vs PBYI — 直观对比
营收规模更大
PBYI
是对方的1.1倍
$68.8M
营收增速更快
CLBK
高出2.0%
27.7%
自由现金流更多
CLBK
多$44.2M
$14.4M
两年增速更快
PBYI
近两年复合增速
17.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $68.8M | $75.5M |
| 净利润 | $15.7M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 28.6% | 22.7% |
| 净利率 | 22.8% | — |
| 营收同比 | 29.7% | 27.7% |
| 净利润同比 | 173.9% | — |
| 每股收益（稀释后） | $0.15 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLBKPBYI
| Q4 25 | $68.8M | $75.5M | ||
| Q3 25 | $67.3M | $54.5M | ||
| Q2 25 | $63.9M | $52.4M | ||
| Q1 25 | $58.8M | $46.0M | ||
| Q4 24 | $46.4M | $59.1M | ||
| Q3 24 | $54.3M | $80.5M | ||
| Q2 24 | $53.3M | $47.1M | ||
| Q1 24 | $49.7M | $43.8M |
净利润CLBKPBYI
| Q4 25 | $15.7M | — | ||
| Q3 25 | $14.9M | $8.8M | ||
| Q2 25 | $12.3M | $5.9M | ||
| Q1 25 | $8.9M | $3.0M | ||
| Q4 24 | $-21.2M | — | ||
| Q3 24 | $6.2M | $20.3M | ||
| Q2 24 | $4.5M | $-4.5M | ||
| Q1 24 | $-1.2M | $-4.8M |
毛利率CLBKPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率CLBKPBYI
| Q4 25 | 28.6% | 22.7% | ||
| Q3 25 | 29.5% | 17.6% | ||
| Q2 25 | 25.8% | 12.7% | ||
| Q1 25 | 20.4% | 8.7% | ||
| Q4 24 | -57.6% | 22.6% | ||
| Q3 24 | 13.5% | 27.4% | ||
| Q2 24 | 9.0% | -4.6% | ||
| Q1 24 | -2.6% | -5.3% |
净利率CLBKPBYI
| Q4 25 | 22.8% | — | ||
| Q3 25 | 22.1% | 16.2% | ||
| Q2 25 | 19.3% | 11.2% | ||
| Q1 25 | 15.1% | 6.5% | ||
| Q4 24 | -45.7% | — | ||
| Q3 24 | 11.4% | 25.2% | ||
| Q2 24 | 8.5% | -9.6% | ||
| Q1 24 | -2.3% | -11.0% |
每股收益（稀释后）CLBKPBYI
| Q4 25 | $0.15 | $0.26 | ||
| Q3 25 | $0.15 | $0.17 | ||
| Q2 25 | $0.12 | $0.12 | ||
| Q1 25 | $0.09 | $0.06 | ||
| Q4 24 | $-0.20 | $0.40 | ||
| Q3 24 | $0.06 | $0.41 | ||
| Q2 24 | $0.04 | $-0.09 | ||
| Q1 24 | $-0.01 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $340.8M | $97.5M |
| 总债务越低越好 | $1.2B | $22.7M |
| 股东权益账面价值 | $1.2B | $130.3M |
| 总资产 | $11.0B | $216.3M |
| 负债/权益比越低杠杆越低 | 1.02× | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资CLBKPBYI
| Q4 25 | $340.8M | $97.5M | ||
| Q3 25 | $253.4M | $94.4M | ||
| Q2 25 | $248.2M | $96.0M | ||
| Q1 25 | $256.1M | $93.2M | ||
| Q4 24 | $289.2M | $101.0M | ||
| Q3 24 | $283.5M | $96.7M | ||
| Q2 24 | $391.1M | $96.8M | ||
| Q1 24 | $373.5M | $107.2M |
总债务CLBKPBYI
| Q4 25 | $1.2B | $22.7M | ||
| Q3 25 | $1.3B | $34.0M | ||
| Q2 25 | $1.3B | $45.3M | ||
| Q1 25 | $1.1B | $56.7M | ||
| Q4 24 | $1.1B | $68.0M | ||
| Q3 24 | $1.4B | $79.3M | ||
| Q2 24 | $1.7B | $90.7M | ||
| Q1 24 | $1.5B | $102.0M |
股东权益CLBKPBYI
| Q4 25 | $1.2B | $130.3M | ||
| Q3 25 | $1.1B | $115.3M | ||
| Q2 25 | $1.1B | $104.7M | ||
| Q1 25 | $1.1B | $97.1M | ||
| Q4 24 | $1.1B | $92.1M | ||
| Q3 24 | $1.1B | $71.1M | ||
| Q2 24 | $1.0B | $48.5M | ||
| Q1 24 | $1.0B | $51.0M |
总资产CLBKPBYI
| Q4 25 | $11.0B | $216.3M | ||
| Q3 25 | $10.9B | $202.9M | ||
| Q2 25 | $10.7B | $194.9M | ||
| Q1 25 | $10.6B | $196.2M | ||
| Q4 24 | $10.5B | $213.3M | ||
| Q3 24 | $10.7B | $220.7M | ||
| Q2 24 | $10.8B | $205.0M | ||
| Q1 24 | $10.6B | $214.1M |
负债/权益比CLBKPBYI
| Q4 25 | 1.02× | 0.17× | ||
| Q3 25 | 1.11× | 0.30× | ||
| Q2 25 | 1.14× | 0.43× | ||
| Q1 25 | 1.01× | 0.58× | ||
| Q4 24 | 1.00× | 0.74× | ||
| Q3 24 | 1.32× | 1.12× | ||
| Q2 24 | 1.61× | 1.87× | ||
| Q1 24 | 1.47× | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $68.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $58.6M | $14.4M |
| 自由现金流率自由现金流/营收 | 85.1% | 19.1% |
| 资本支出强度资本支出/营收 | 14.3% | 0.0% |
| 现金转化率经营现金流/净利润 | 4.36× | — |
| 过去12个月自由现金流最近4个季度 | $95.1M | $41.7M |
8季度趋势，按日历期对齐
经营现金流CLBKPBYI
| Q4 25 | $68.4M | $14.4M | ||
| Q3 25 | $31.0M | $9.7M | ||
| Q2 25 | $14.6M | $14.1M | ||
| Q1 25 | $-1.6M | $3.6M | ||
| Q4 24 | $33.3M | $15.6M | ||
| Q3 24 | $-28.3M | $11.0M | ||
| Q2 24 | $18.6M | $1.0M | ||
| Q1 24 | $14.1M | $11.2M |
自由现金流CLBKPBYI
| Q4 25 | $58.6M | $14.4M | ||
| Q3 25 | $28.1M | $9.7M | ||
| Q2 25 | $12.9M | $14.1M | ||
| Q1 25 | $-4.5M | $3.6M | ||
| Q4 24 | $25.9M | $15.6M | ||
| Q3 24 | $-31.1M | $11.0M | ||
| Q2 24 | $17.2M | $1.0M | ||
| Q1 24 | $12.5M | — |
自由现金流率CLBKPBYI
| Q4 25 | 85.1% | 19.1% | ||
| Q3 25 | 41.8% | 17.7% | ||
| Q2 25 | 20.2% | 26.8% | ||
| Q1 25 | -7.6% | 7.7% | ||
| Q4 24 | 55.7% | 26.4% | ||
| Q3 24 | -57.3% | 13.7% | ||
| Q2 24 | 32.3% | 2.1% | ||
| Q1 24 | 25.1% | — |
资本支出强度CLBKPBYI
| Q4 25 | 14.3% | 0.0% | ||
| Q3 25 | 4.2% | 0.0% | ||
| Q2 25 | 2.7% | 0.0% | ||
| Q1 25 | 4.9% | 0.1% | ||
| Q4 24 | 16.0% | 0.0% | ||
| Q3 24 | 5.1% | 0.0% | ||
| Q2 24 | 2.6% | 0.0% | ||
| Q1 24 | 3.4% | 0.0% |
现金转化率CLBKPBYI
| Q4 25 | 4.36× | — | ||
| Q3 25 | 2.08× | 1.10× | ||
| Q2 25 | 1.19× | 2.41× | ||
| Q1 25 | -0.18× | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | -4.57× | 0.54× | ||
| Q2 24 | 4.09× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
